https://www.cochrane.org/fr/CD014869/LIVER_quels-sont-les-benefices-et-les-risques-du-tamoxifene-dans-le-traitement-des-personnes-atteintes-dun 2024 United Kingdom review of literature french abstract disease tamoxifen persons carcinoma, hepatocellular risk assessment tamoxifen hepatocellular carcinoma, nos risks and benefits disease of liver, nos
--- https://syngof.fr/documents-utiles/covid-19-recommandations-de-strategies-de-prevention-des-evenements-thromboemboliques-veineux-des-femmes-covid-et-utilisant-un-traitement-hormonal/ 2020 France coronavirus infections pneumonia, viral guideline menopause Hormonal contraception female tamoxifen hormonotherapy hospital admission, nos hormones hormone, nos women contraception, nos menopause, nos risk contraception tamoxifen estrogen replacement therapy hospitalization menopause female hormones risk pandemics COVID-19